These results suggest that IgM aCL and aβ2GPI should be tested in first-line evaluation of suspected obstetric APS, but could be evaluated as second-line test for risk assessment of thrombotic APS patients [126]. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.